A detailed history of Donaldson Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Donaldson Capital Management, LLC holds 468,612 shares of ABBV stock, worth $83.6 Million. This represents 3.57% of its overall portfolio holdings.

Number of Shares
468,612
Previous 464,969 0.78%
Holding current value
$83.6 Million
Previous $79.8 Million 16.04%
% of portfolio
3.57%
Previous 3.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$163.84 - $199.33 $596,869 - $726,159
3,643 Added 0.78%
468,612 $92.5 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $1.31 Million - $1.53 Million
-8,455 Reduced 1.79%
464,969 $79.8 Million
Q1 2024

Apr 22, 2024

BUY
$159.82 - $182.1 $355,439 - $404,990
2,224 Added 0.47%
473,424 $86.2 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $1.68 Million - $1.89 Million
-12,194 Reduced 2.52%
471,200 $73 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $723,657 - $837,739
5,417 Added 1.13%
483,394 $72.1 Million
Q2 2023

Jul 17, 2023

BUY
$132.51 - $164.9 $703,760 - $875,783
5,311 Added 1.12%
477,977 $64.4 Million
Q1 2023

Apr 13, 2023

BUY
$144.61 - $166.54 $418,790 - $482,299
2,896 Added 0.62%
472,666 $75.3 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $1.01 Million - $1.21 Million
7,287 Added 1.58%
469,770 $76 Million
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $702,320 - $805,515
5,233 Added 1.14%
462,483 $62.1 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $13.7 Million - $17.4 Million
-99,622 Reduced 17.89%
457,250 $70 Million
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $57,543 - $71,395
-436 Reduced 0.08%
556,872 $90.3 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $953,870 - $1.21 Million
8,879 Added 1.62%
557,308 $75.5 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $718,838 - $815,989
6,756 Added 1.25%
548,429 $59.2 Million
Q2 2021

Jul 28, 2021

BUY
$105.21 - $117.21 $1.26 Million - $1.4 Million
11,929 Added 2.25%
541,673 $61 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $811,852 - $893,752
7,936 Added 1.52%
529,744 $57.3 Million
Q4 2020

Jan 11, 2021

SELL
$80.49 - $108.67 $103,912 - $140,292
-1,291 Reduced 0.25%
521,808 $55.9 Million
Q3 2020

Nov 02, 2020

SELL
$85.91 - $100.83 $963,652 - $1.13 Million
-11,217 Reduced 2.1%
523,099 $45.8 Million
Q2 2020

Jul 27, 2020

BUY
$73.37 - $98.18 $390,695 - $522,808
5,325 Added 1.01%
534,316 $52.5 Million
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $2.32 Million - $3.52 Million
35,961 Added 7.29%
528,991 $40.3 Million
Q4 2019

Jan 14, 2020

BUY
$72.13 - $90.25 $800,138 - $1 Million
11,093 Added 2.3%
493,030 $43.7 Million
Q3 2019

Nov 04, 2019

BUY
$62.98 - $75.72 $6.35 Million - $7.63 Million
100,832 Added 26.46%
481,937 $36.5 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $584,795 - $747,505
8,901 Added 2.39%
381,105 $27.7 Million
Q1 2019

Apr 01, 2019

SELL
$77.14 - $90.79 $1.58 Million - $1.85 Million
-20,431 Reduced 5.2%
372,204 $30 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $12,300 - $15,169
158 Added 0.04%
392,635 $36.2 Million
Q3 2018

Nov 06, 2018

SELL
$88.91 - $98.84 $110,781 - $123,154
-1,246 Reduced 0.32%
392,477 $37.1 Million
Q2 2018

Aug 07, 2018

SELL
$89.78 - $106.23 $405,266 - $479,522
-4,514 Reduced 1.13%
393,723 $36.5 Million
Q1 2018

Apr 30, 2018

SELL
$92.01 - $123.21 $1.18 Million - $1.58 Million
-12,812 Reduced 3.12%
398,237 $37.7 Million
Q4 2017

Jan 30, 2018

BUY
$89.56 - $98.21 $36 Million - $39.5 Million
402,245 Added 4568.89%
411,049 $39.8 Million
Q4 2017

Jan 26, 2018

SELL
$89.56 - $98.21 $36.6 Million - $40.2 Million
-409,068 Reduced 97.89%
8,804 $851,000
Q3 2017

Nov 08, 2017

BUY
$69.85 - $89.22 $29.2 Million - $37.3 Million
417,872
417,872 $37.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Donaldson Capital Management, LLC Portfolio

Follow Donaldson Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donaldson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donaldson Capital Management, LLC with notifications on news.